Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer

NCT00284180 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms
Breast Cancer

Interventions

DRUG: Vinflunine
DRUG: Trastuzumab

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]